HPR17 National Reimbursement Drug List in China: Changing Dynamics and Trend and Price Determination of Formulation Innovation Drugs
Dec 1, 2024, 00:00
10.1016/j.jval.2024.10.1444
https://www.valueinhealthjournal.com/article/S1098-3015(24)04307-9/fulltext
Title :
HPR17 National Reimbursement Drug List in China: Changing Dynamics and Trend and Price Determination of Formulation Innovation Drugs
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)04307-9&doi=10.1016/j.jval.2024.10.1444
First page :
Section Title :
Open access? :
No
Section Order :
10910